证券代码：002243 证券简称：通产丽星 深圳市通产丽星股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □新闻发布会 路演活动 | | | ...

证券代码：002243 证券简称：通产丽星 深圳市通产丽星股份有限公司投资者关系活动记录表 编号：063 | --- | --- | --- | |----------------|------------------------|-------------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | √ 媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 （电话会议） | | | 参与单位名称及 | 证券时报 记者 周少杰 | | | 人员姓名 | | | | 时间 | 2017 年 12 月 | 18 日 10:00 | | 地点 | 公司 | | | 上市公司接待人 | 董事长陈寿先生 | | | 员姓名 | | | | 投资者关系活动 | | 记者：公司三季报预计，全年净利润预计 4200 万元至 5000 | | 主要内容介绍 | 万元，超额完成年初设定 | 2800 万元的目标，今年 ...

证券代码：002243 证券简称：通产丽星 编号：064 通产丽星投资者关系活动记录表 | --- | --- | --- | |--------------|-------------------------------|-----------------------------------------------------| | | | | | | █ | 特定对象调研 □分析师会议 | | | □ | 媒体采访 □业绩说明会 | | 投资者关系活 | □新闻发布会 □路演活动 | | | 动类别 | □ 现场参观 □电话通讯 | | | | □ | 其他 （请文字说明其他活动内容） | | | | 深圳君择投资控股有限公司 黄登峰 ; | | | 深圳君择投资控股有限公司 湛选 | ; | | 参与单位名称 | | 深圳君择投资控股有限公司 张达维; | | 及人员姓名 | | 深圳君择投资控股有限公司 梁欣欣 ; | | | | 深圳君择投资控股有限公司 郑钊奇 | | 时间 | 2018 年 07 月 03 | 日 | | 地点 | 公司坪地生产基地 | | | 上市公司接待 | 副总经理/董秘 ...

深圳市力合科创股份有限公司 投资者关系活动记录表 编号：2021-004 | --- | --- | --- | |-------------------------|----------------------------------|------------------------------------------------------------| | | | | | | √特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | | | | | 参与单位名称及人员 姓名 | 恒大人寿保险有限公司 | 投资管理中心股票投资部 巩伟 | | 时间 | 2021 年 6 月 23 日 | 15:00 | | 地点 | 深圳市高新技术产业园清华信息港 | | | 上市公司接待人员姓 名 | 董事会秘书 于喆 | | | | 1 、公司的科技资源主要来源？ | | | | | 答：公司的核心优势之一就是拥有优质科技创新资源聚集、挖掘、 | | ...

深圳市力合科创股份有限公司 投资者关系活动记录表 编号：2021-003 | --- | --- | --- | --- | --- | --- | |-------------------------|-------------------------------------------------|-------------|--------------------------------------------------------|-------|-------| | | | | | | | | | √特定对象调研 □分析师会议 | | | | | | | □媒体采访 □业绩说明会 | | | | | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | | | | | □现场参观 | | | | | | | □其他 | | （请文字说明其他活动内容） | | | | | 上海申银万国证券研究所有限公司 | 屠亦婷 | | | | | | 深圳微禾投资有限公司 深圳海富凌资本管理有限公司 | 邓飞 陈凌 | | | | | 参与单位名称及人员 姓名 | 深圳清水源投资管理有限公司 | 吴 ...

深圳市力合科创股份有限公司 投资者关系活动记录表 编号：2021-002 | --- | --- | --- | |-----------------------|---------------------------------|----------------------------------------------------------| | | | | | | √特定对象调研 | □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动类别 | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及人员 | 兴业证券 | 社会服务行业分析师 王越 | | 姓名 | 兴业证券 | 深圳分公司投资银行部 张宇骏 | | 时间 | 2021 年 5 月 10 日 | 14:00 | | 地点 | | 深圳市高新技术产业园清华信息港科研楼 7 楼 705 | | 上市公司接待人员姓 名 | 董事会秘书 于喆 | | | | 1、公司可进行对标的公司有哪些？ | | | | | 答：公司科技创新服务是一个体系 ...

Group 1: Company Overview and Services - The company's profit model for technology innovation services includes basic incubation services, park carrier sales, park operation services, system promotion, industrial consulting services, and talent training services [2] - The company has established seven overseas innovation centers in North America, Europe, Israel, and Japan to expand partnerships and access advanced technology achievements [3] Group 2: Financial Performance - The net cash flow from operating activities for the first three quarters of the year was -1.105 billion yuan, primarily due to increased expenditures on park carrier construction [2] - The company successfully raised 5 billion yuan for the "Lihe Zhongkai Innovation Base" project and has raised a total of 11 billion yuan from a planned 42 billion yuan bond issuance [3] Group 3: Investment and Equity - The company's equity stake in incubated projects typically ranges from 5% to 20%, depending on specific project circumstances [3] - After a capital increase on November 12, the company will hold a 47% equity stake in Lihe Yunji through its wholly-owned subsidiary [3] Group 4: Market Opportunities - Lihe Yunji's self-disinfecting antiviral materials are effective against COVID-19 and can be applied in various settings, including airports, hospitals, and schools [4] - The company is currently negotiating multiple projects involving Lihe Yunji's materials, although there is some uncertainty regarding the outcomes [4] Group 5: Future Development - The company aims to cultivate influential and high-growth technology enterprises by focusing on strategic emerging industries outlined in the national "14th Five-Year Plan" [4]

Group 1: Investor Relations Activities - The investor relations activities included specific object research and a telephone conference [1] - Participating institutions included various fund management companies and investment groups [1] Group 2: Company Revenue and Business Model - In 2020, the company achieved total revenue of CNY 2.184 billion, with new materials contributing approximately CNY 1.48 billion (68%) and technology innovation services contributing about CNY 690 million (32%) [5] - In the first half of 2021, total revenue was CNY 1.013 billion, with new materials contributing around CNY 677 million (67%) and technology innovation services contributing about CNY 328 million (32%) [5] Group 3: Investment and Incubation Projects - The company focuses on emerging industries such as new generation information technology, intelligent manufacturing, new energy materials, and life health [3] - Notable incubated projects include companies listed on the stock market and those recognized as "little giants" by the Ministry of Industry and Information Technology [3] Group 4: Core Advantages and Innovations - The company's core advantages include a rich pool of technology innovation resources and a strong incubation capability [3] - The self-disinfecting antiviral materials from Lihai Cloud have begun industrialization, with market prices of CNY 100 per square meter for the water-based agent and CNY 380 per square meter for the antiviral film [4] Group 5: Future Plans and Strategic Focus - The company plans to enhance technology transfer efforts and deepen cooperation with universities and research institutions [6] - Future focus areas include expanding into health products, food, and light medical aesthetics, while maintaining no plans for business divestiture [6] Group 6: Shareholder Information - As of November 29, 2021, a major shareholder reduced their holdings by 12,229,190 shares, accounting for 1.0102% of the total share capital [7] - The company has a plan for the release of restricted shares, expected to occur by the end of the year [7]

Group 1: Company Overview and Strategic Focus - The company focuses on developing new generation information technology, intelligent manufacturing, new energy materials, and life health industries, aligning with national strategic emerging industries [1][5]. - The company holds a 15.9% stake in Qingyan Environment [3]. Group 2: Financial and Investment Insights - The company has a bond issuance limit of 42 billion, of which 11 billion has been issued, with the validity of the bond until August 25, 2022 [3]. - The company does not currently have plans for equity financing but will disclose any future plans as required [7]. Group 3: Product Development and Market Expansion - The self-disinfecting antiviral materials have begun industrialization and are actively expanding into the market, with a production capacity target of 10 billion [2][4]. - The self-disinfecting products are expected to have a gross margin of at least 30% [2]. Group 4: Research and Development - The company is conducting research on fullerene applications in cosmetics but has not yet formed industrialization conditions [7]. - The self-disinfecting products are designed to be effective against various viruses, but specific efficacy against variants like Omicron requires rigorous testing [7]. Group 5: Investor Relations and Communication - The company has been actively engaging with investors through various activities, including institutional research and public disclosures [5][6]. - The company encourages investors to check the National Intellectual Property Administration for patent information related to their products [2][4].

Group 1: Financial Overview - The overall valuation of Lihua Yunjing is estimated at RMB 14,024.39 million as of July 7, 2021, based on an assessment report [1] - The company plans to increase capital for Lihua Yunjing, with a total investment of RMB 488 million [1] Group 2: Market and Orders - Lihua Yunjing is actively expanding its market, particularly in response to a notice from the Shenzhen Science and Technology Innovation Committee regarding the use of its self-disinfecting antiviral materials [2] - The company is in discussions with various projects, including quarantine hotels, but the order situation remains uncertain [2] Group 3: Shareholder Actions - The third-largest shareholder, Jiashi Yuantai, plans to reduce its holdings by up to 64,054,790 shares, representing 5.2911% of the total share capital [2] - As of November 29, 2021, Jiashi Yuantai has already reduced its holdings by 12,229,190 shares, accounting for 1.0102% of the total share capital [2] Group 4: Unlocking of Restricted Shares - Approximately 50 million restricted shares are expected to be unlocked by the end of the year, following a 24-month lock-up period [3] Group 5: Business Model and Advantages - The company's technology innovation services generate revenue from various sources, including incubation services, park operations, and industry consulting [3] - The core advantage of the investment incubation business lies in the ability to gather and nurture high-quality technological innovation resources, reducing entrepreneurial risks for tech companies [3] Group 6: Future Prospects - The company aims to cultivate influential and high-growth technology enterprises by focusing on strategic emerging industries outlined in the national "14th Five-Year Plan" [4]